
Juvenile myelomonocytic leukemia: Abbreviated JMML. A rare <a href="https://www.medicinenet.com/cancer/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">cancer</a> of the myeloid cells in the bone marrow, accounting for less than 1% of all childhood <a href="https://www.medicinenet.com/leukemia/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">leukemia</a>. JMML is most common in children under four years of age, especially those with genetic disorders called neurofibromatosis 1 (NF1) and <a href="https://www.medicinenet.com/noonan_syndrome/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">Noonan syndrome</a>.  Up to 14% of cases of JMML occur in children with NF1. Few approaches other than hematopoietic stem cell transplantation have resulted in long-term survival for this disease. JMML was formerly called juvenile chronic myelogenous leukemia (juvenile chronic myeloid leukemia, juvenile CML or JCML).